Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
532523 | BSE
-3.25
-1.34%
Other
Other
31/03/2023
08/12/2023
238.90
242.70
243.85
236.80
Biocon Limited a biopharmaceutical company manufactures pharmaceuticals and medicinal chemical and botanical products. The company operates through Small Molecules Biologics Branded Formulations and Research Services segments. It focuses in the areas of diabetes oncology immunology dermatology ophthalmology neurology rheumatology and inflammatory diseases. The company provides biosimilars comprising recombinant human insulin insulin glargine biosimilar trastuzumab and other biopharmaceuticals; small molecules such as active pharmaceutical ingredients and generic formulations; and branded formulation products under the Insugen Basalog BIOMAb EGFR CANMAb and ALZUMAb brands. It is also involved in the integrated discovery development and manufacturing services for small and large molecules antibody-drug conjugates and oligonucleotides. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru India.
View LessLow 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
Price Below SMA10D
Midcap (2B - 10B USD)
Weak P/E, and PEG ratio indicator
No Dividends (Dividend Yield = 0%)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
15.4%1 month
12.5%3 months
23.8%6 months
28.0%73.25
0
7.56
1.91
0.66
29.05
8.03
0
15.59B
523.92B
6.28B
0
13.73
-22.50
11.00
10.02
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
13.65
Range1M
22.45
Range3M
62.45
Rel. volume
0.56
Price X volume
20.84M